title: Tolerability and efficacy of rituximab-containing immunochemotherapy in patients with B-cell non-Hodgkin lymphoma receiving hemodialysis.
authors.affiliation: a Department of Hematology , Kobe City Medical Center General Hospital , Kobe , Japan ;
authors.forename: Yotaro
authors.initials: Y
authors.lastname: Ochi
authors.affiliation: b Department of Cell Therapy , Institute of Biomedical Research and Innovation , Kobe , Japan ;
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Hiramoto
authors.affiliation: a Department of Hematology , Kobe City Medical Center General Hospital , Kobe , Japan ;
authors.forename: Yuichiro
authors.initials: Y
authors.lastname: Ono
authors.affiliation: a Department of Hematology , Kobe City Medical Center General Hospital , Kobe , Japan ;
authors.forename: Satoshi
authors.initials: S
authors.lastname: Yoshioka
authors.affiliation: a Department of Hematology , Kobe City Medical Center General Hospital , Kobe , Japan ;
authors.forename: Sumie
authors.initials: S
authors.lastname: Tabata
authors.affiliation: a Department of Hematology , Kobe City Medical Center General Hospital , Kobe , Japan ;
authors.forename: Noboru
authors.initials: N
authors.lastname: Yonetani
authors.affiliation: a Department of Hematology , Kobe City Medical Center General Hospital , Kobe , Japan ;
authors.forename: Akiko
authors.initials: A
authors.lastname: Matsushita
authors.affiliation: c Department of Clinical Pathology , Kobe City Medical Center General Hospital , Kobe , Japan.
authors.forename: Yukihiro
authors.initials: Y
authors.lastname: Imai
authors.affiliation: a Department of Hematology , Kobe City Medical Center General Hospital , Kobe , Japan ;
authors.forename: Takayuki
authors.initials: T
authors.lastname: Ishikawa
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000139:chemically induced; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008224:Lymphoma, Follicular / Q000150:complications / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced; D012074:Remission Induction; D006435:Renal Dialysis; D000069283:Rituximab / Q000008:administration & dosage / Q000009:adverse effects; D016019:Survival Analysis
chemical_list: D000069283:Rituximab